| __timestamp | Eli Lilly and Company | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 31354781 |
| Thursday, January 1, 2015 | 4796400000 | 43445817 |
| Friday, January 1, 2016 | 5243900000 | 66489820 |
| Sunday, January 1, 2017 | 5281800000 | 96886134 |
| Monday, January 1, 2018 | 5051200000 | 153793000 |
| Tuesday, January 1, 2019 | 5595000000 | 148369000 |
| Wednesday, January 1, 2020 | 6085700000 | 151934000 |
| Friday, January 1, 2021 | 7025900000 | 198532000 |
| Saturday, January 1, 2022 | 7190800000 | 112128000 |
| Sunday, January 1, 2023 | 9313400000 | 76192000 |
| Monday, January 1, 2024 | 14271000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Eli Lilly and Company has consistently outpaced TG Therapeutics, Inc. in R&D investment. From 2014 to 2023, Eli Lilly's R&D expenses surged by nearly 97%, peaking at approximately $9.3 billion in 2023. In contrast, TG Therapeutics, while showing growth, increased its R&D spending by about 143%, reaching around $76 million in the same year.
This stark difference highlights Eli Lilly's robust financial capacity and strategic focus on pioneering new treatments. Meanwhile, TG Therapeutics, a smaller player, demonstrates a commendable commitment to innovation relative to its size. As the pharmaceutical industry continues to prioritize groundbreaking research, these spending trends offer a glimpse into the future trajectories of these two companies.
Research and Development Investment: Eli Lilly and Company vs Takeda Pharmaceutical Company Limited
Research and Development Investment: Eli Lilly and Company vs Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Eli Lilly and Company vs Ultragenyx Pharmaceutical Inc.
Eli Lilly and Company vs ImmunityBio, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Novartis AG and TG Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated or TG Therapeutics, Inc.: Who Invests More in Innovation?
Incyte Corporation or TG Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and TG Therapeutics, Inc.
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and TG Therapeutics, Inc.
R&D Insights: How TG Therapeutics, Inc. and Amicus Therapeutics, Inc. Allocate Funds
R&D Insights: How TG Therapeutics, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How TG Therapeutics, Inc. and Mesoblast Limited Allocate Funds